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Over the past decades, the incidence of non-Hodgkin’s lymphoma
(NHL) has increased in many western countries (Devesa and
Fears, 1992) for reasons that are largely unknown. Chronic inflam-
mation has been linked to increased occurrence of NHL (Holmes
et al, 1989; Baecklund et al, 1998). Several moderate-sized case-
control studies of patients with NHL have found associations with
histories of chronic infections including tuberculosis (Bernard et al,
1984; Franceschi et al, 1989; Doody et al, 1992; La Vecchia
et al, 1992; Tavani et al, 2000). During the first half of the 20th
century, the incidence and case-fatality of tuberculosis decreased
markedly (The Swedish Institute for Infectious Disease Control,
1989), in the same birth cohorts that have later experienced an
increasing incidence of NHL. Based on this ecological correlation,
and on the positive association between the two diseases reported
in case-control studies, we hypothesized that individuals with a
history of tuberculosis would be at increased risk of NHL. 
At two Swedish tuberculosis dispensaries and one sanatorium
with population-based catchment areas, we identified 5199 indi-
viduals consecutively diagnosed or admitted with tuberculosis in
the years 1939–1960. For each individual, we collected informa-
tion on date of birth, sex, date of entry (diagnosis or admission),
location of tuberculosis (pulmonary vs extrapulmonary), result of
sputum microsopy on admission (sanatorium patients up to 1953
only), admission to thoracic surgery (sanatorium patients up to
1953 only), and socioeconomic status (white collar, blue collar,
unskilled worker, or missing, categorized on the basis of the oc-
cupation of the head of the family). The cohort was linked to
the population-based Swedish cancer register for 1958–1996
(Mattsson and Wallgren, 1984), cause of death register for
1952–1996, and to the population register. 139 individuals were
lost to follow-up. Ten individuals were excluded due to data irregu-
larities precluding follow-up, leaving 5050 individuals (2680
males and 2370 females) in the cohort. Of these, 3353 individuals
entered 1939–1952 and 1697 entered 1953–1960. Standardized
all-cause mortality ratios (SMR), and standardized incidence
ratios (SIR) of malignancies at all sites, of NHL, and of Hodgkin’s
disease were calculated by dividing the observed number of events
with that expected according to sex-, age- and calendar period-
specific rates. Start of follow-up was set to last of: date of diag-
nosis of tuberculosis or 1 January 1952 (SMR) or 1958 (SIR). End
of follow-up was set to date of death, emigration, or 31 December
1996, whichever occurred first. 95% confidence intervals (95%
CI) were calculated assuming a Poisson-distribution for the
observed cases (Breslow and Day, 1987). Poisson-regression was
used to compare risk estimates (Breslow and Day, 1987). 
2797 deaths were registered during 163 270 person-years of
follow-up, the SMR being 1.40 (95% CI = 1.35–1.46). The SMR
declined with time since tuberculosis, and was 1.17 (95% CI =
1.07–1.27) after 40 or more years since tuberculosis (P for linear
trend < 0.0001). Individuals who entered the cohort 1939–1952 had
a significantly higher SMR than those who entered 1953–1960
(adjusted for time since tuberculosis, data not shown). Admission
(vs no admission) to thoracic surgery, positive (vs negative) direct
microscopy, extrapulmonary (vs pulmonary) tuberculosis, and low
(vs high) socioeconomic status were each associated with signifi-
cantly higher SMRs (data not shown). 1073 cancers were registered
and the SIR was 1.20 (95% CI = 1.13–1.28). The all-site SIRs were
similar in all latency periods and did not vary significantly with
calendar period of entry, admission to thoracic surgery, sputum
smear status, location of tuberculosis, or socioeconomic status
(data not shown). A total of 33 cases of NHL were registered and
the SIR was 1.42 (95% CI = 0.98–1.99) (Table 1). The relative risk
was highest after 40 or more years following entry (SIR = 2.25,
95% CI = 1.23–3.78, n = 14). The SIRs were close to unity in each
5-year interval up to 40 years since the tuberculosis, but above 2.0
in each subsequent interval (data not shown). Individuals who
entered the cohort 1939–1952 had a significantly higher risk (SIR =
1.77, 95% CI = 1.16–2.57,  n = 27) than those who entered
1953–1960, whose risk was not elevated (Table 1). When adjusted
for each other, the elevated risks associated with more than 40 years
of latency, and with entry during 1939–1952, remained largely
similar yet no longer significant. Male sex, positive (vs negative)
sputum smear, and admission (vs no admission) to thoracic surgery
were associated with non-significantly higher SIRs, and the risks
were similar for pulmonary and extrapulmonary tuberculosis (data
not shown). However, 14 of the 33 cases of NHL occurred among
individuals with either positive sputum smear or admission to
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individuals not admitted to surgery and with negative sputum
microscopy (SIR = 0.70, 95% CI = 0.23–1.63), and 14 among indi-
viduals with no information on either characteristic (SIR = 1.26,
95% CI = 0.69–2.12, P for linear trend over estimates = 0.003).
Among those smear-positive or admitted to surgery, the risk was
significantly higher after 40 or more years since tuberculosis
(SIR = 5.34, 95% CI = 2.44–10.1, n = 9) compared to 0–39 years
since tuberculosis (Table 1). Alternative categorizations of latency
time resulted in a similar risk pattern. The SIR of Hodgkin’s disease
was not significantly elevated (SIR = 1.65, 95% CI = 0.71–3.26,
n = 8) but displayed a similar pattern as NHL with the highest point
estimate 40 or more years since the tuberculosis (SIR = 4.18, 95%
CI = 0.51–15.1, n = 2). 
This study indicates that the risk of NHL following tuberculosis
is increased, but only among individuals diagnosed with tubercu-
losis before 1953, and among them, in particular among individu-
als with severe tuberculosis. The increased overall risk of NHL
corroborates the results of several case-control studies of patients
with NHL (Bernard et al, 1984; Franceschi et al, 1989; Doody
et al, 1992; La Vecchia et al, 1992; Tavani et al, 2000), although
some have found no association (Tielsch et al, 1987; Cartwright
et al, 1988). None of the case-control studies have, however,
included characteristics of the tuberculosis. Two cohort-studies
(performed for other purposes) of patients with tuberculosis
analysed the risk for NHL (Howe et al, 1979; Davis et al, 1989)
but neither found a positive association. However, in one study
patients were followed for only 23 years, and proportionate
mortality ratios were used which are inherently difficult to inter-
pret in the presence of competing mortality (Howe et al, 1979).
The other found an increased overall risk of dying from Hodgkin’s
disease but no increased risk for the combined group of non-
Hodgkin’s lymphoma, multiple myeloma and polycythaemia vera.
No separate analysis of non-Hodgkin’s lymphoma was performed
(Davis et al, 1989). No analysis of latency was presented. An
increased risk for NHL may thus well have been concealed in both
these studies. 
Patients with tuberculosis may differ from the general popula-
tion with respect to several factors, such as socioeconomic status,
use of tobacco, alcohol and coffee, exposure to ionizing radiation
and isoniazid, and body-mass index. Since none of these factors
have been consistently identified as risk factors for NHL (Stott
et al, 1976; Franceschi et al, 1989; Devesa and Fears, 1992; La
Vecchia et al, 1992; Ron et al, 1994; Tavani et al, 1994; Nelson 
et al, 1997; Adami et al, 1998; Holly et al, 1999; Zhang et al,
1999), substantive confounding by these factors is unlikely.
Surveillance bias, that is, if individuals with a history of tubercu-
losis received closer medical surveillance than healthy individuals,
would more likely have resulted in generally increased risks rather
than the observed calendar period-dependent risks. The classifica-
tion of sputum smear status, location of tuberculosis, and surgical
treatment does not take into consideration later relapses. Bias
resulting from such misclassification would, however, attenuate
rather than create differences between exposure-groups, and is
thus an unlikely explanation for the observed variations in risk.
The lack of information on severity during the 1953–1960 period
of entry precludes a more detailed risk-analysis within this
interval. However, it does not change the absence of overall risk
increase during the interval, although the low number of expected
cases in the long latency interval during this period makes it diffi-
cult to completely exclude a long-term effect. Validation-studies
have found that one third of the registered cases of Hodgkin’s
disease during the 1970s were misclassified NHL (Martinsson et
al, 1992). We therefore also assessed the risk of Hodgkin’s disease.
The similarity of the SIRs for NHL and for Hodgkin’s disease may
be due to misdiagnosis of the former as the latter. 
Severe tuberculosis (defined as individuals with positive
sputum smear or admission to surgery, who had the highest overall
mortality) was associated with a markedly increased risk of NHL.
In contrast, individuals diagnosed after 1952, when curative
chemotherapy (isoniazid) was introduced, were not at increased
risk of NHL. Inflammatory intensity and duration are important
risk determinants for malignant lymphomas complicating rheuma-
toid arthritis and coeliac disease (Holmes et al, 1989; Baecklund
et al, 1998) and our results suggest that these factors also may
influence the association between tuberculosis and NHL: limited
infection did not increase NHL risk (tuberculosis diagnosed after
1952 or uncomplicated tuberculosis diagnosed 1939–1952), while
the highest inflammatory load was associated with the highest risk
increase (long-standing, severe tuberculosis diagnosed 1939–1952).
There is evidence of genetic variation in the susceptibility to
tuberculosis, through genes encoding components of the inflam-
matory response (Bellamy et al, 1998). Since it has been proposed
that low-secretor genotypes of TNF-alpha are associated with
increased susceptibility to follicular NHL (Fitzgibbon et al, 1999),
an alternative interpretation of our results is that NHL is a result of
increased susceptibility rather than a consequence of tuberculosis
itself. 
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Table 1 Standardized incidence ratio (SIR) of non-Hodgkin’s lymphoma 1958–1996 with 95% confidence interval (95% CI) and number of observed cases (n)
by calendar period of entry, severity of tuberculosis (defined by sputum smear status and admission to thoracic surgery) and time since tuberculosis, in a cohort
of 5050 Swedish patients with tuberculosis diagnosed 1939–1960 and followed up until 1997 
SIR (95% CI) n
Period of entry Subjects 0–39 years since TB 40+ years since TB All latency intervals 
1939–1952 All 1.38 (0.73–2.34) 13 2.42 (1.33–4.07) 14 1.77 (1.16–2.57) 27a
Smear positive or operated 1.48 (0.48–3.46) 5 5.34  (2.44–10.1) 9b,c 2.77 (1.51–4.65) 14d
No information 2.22 (0.72–5.17) 5 3.70  (0.76–10.8) 3 2.61  (1.13–5.14) 8 
Smear negative, not operated 0.77 (0.16–2.26) 3  0.61  (0.07–2.20) 2 0.70  (1.23–1.63) 5 
1953–1960 All 0.79 (0.29–1.73) 6 0.00  (0.00–8.52) 0 0.75  (0.27–1.63) 6 
Both periods All 1.11 (0.67–1.74) 19 2.25 (1.23–3.78) 14e 1.42 (0.98–1.99) 33 
aP for difference compared to entry in 1953–1960 = 0.04; bP for difference compared to 0–39 years since tuberculosis = 0.02; cP for linear trend from no, through
missing, to yes = 0.001; dP for difference compared to individuals with negative sputum smear and not operated on = 0.004; eP for difference compared to 0–39
years since tuberculosis = 0.05 In conclusion, this study suggests that the risk of NHL is
increased in individuals with a history of tuberculosis, but only
among individuals with tuberculosis, particularly severe, diag-
nosed a long time ago. Whether the observed risk increase is due to
the tuberculosis itself, an underlying susceptibility, or associated
exposures is not clear. Our results raise the question whether one
reason behind the increasing incidence of NHL over the past
decades is the increasing survival into older age groups of indi-
viduals with what used to be lethal infections of early adulthood,
such as tuberculosis. 
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